Alaunos Therapeutics, Inc.

TCRT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001107421

SEC filings (opens in a new tab)

No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Alaunos Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of TCRT: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	156	1	163	+8
Shares	112.7M	21.3K	106.6M	−6.11M (−5.4%)
Value	$297.6M	$56.0K	$194.1M	−$103.4M (−34.8%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to TCRT in Q3 2021
Institution	Shares	Value	% of portfolio
Avidity Partners Management LP	3,000,000	$5.46M	0.14%
Point72 Asset Management, L.P.	1,369,900	$2.49M	0.01%
Marshall Wace North America L.P.	939,821	$1.71M	0.01%
Marshall Wace, LLP	518,868	$944.0K	0.00%
Virtu Financial LLC	59,527	$108.0K	0.01%
Sigma Planning Corp	55,310	$101.0K	0.00%
Two Sigma Securities, LLC	35,433	$64.0K	0.01%
Summit Trail Advisors, LLC	27,760	$51.0K	0.00%
E Fund Management Co., Ltd.	22,684	$41.0K	0.00%
Janus Henderson Group PLC	21,615	$39.0K	0.00%
Pictet Asset Management SA	21,300	$39.0K	0.00%
Mutual Advisors, LLC	17,400	$32.0K	0.00%
Gateway Advisory, LLC	15,301	$28.0K	0.01%
Five Oceans Advisors	15,307	$28.0K	0.03%
Cetera Advisors LLC	14,258	$26.0K	0.00%
ARGI Investment Services, LLC	13,000	$24.0K	0.00%
Bokf, NA	12,697	$23.0K	0.00%
Mackenzie Financial Corp	12,318	$22.0K	0.00%
Wetherby Asset Management Inc	10,410	$19.0K	0.00%
Pasadena Private Wealth, LLC	10,596	$19.0K	0.01%
Allworth Financial LP	5,862	$11.0K	0.00%
Ellevest, Inc.	3,490	$6.00K	0.00%
Parallel Advisors, LLC	2,978	$5.00K	0.00%
Lindbrook Capital, LLC	1,721	$3.00K	0.00%
PSI Advisors, LLC	1,000	$2.00K	0.00%
IFP Advisors, Inc	197	$1.00K	0.00%
Quadrant Capital Group LLC	230	$0	0.00%

Sold out (19)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of TCRT in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Miller Value Partners, LLC	10,317,698	$27.2M
ExodusPoint Capital Management, LP	68,881	$182.0K
AXA S.A.	60,300	$159.0K
Qube Research & Technologies Ltd	48,099	$127.0K
XTX Topco Ltd	47,951	$127.0K
Exane Derivatives	45,227	$108.5K
Lincoln National Corp	37,500	$99.0K
Susquehanna Fundamental Investments, LLC	21,925	$58.0K
Jump Financial, LLC	17,300	$46.0K
Wolverine Trading, LLC	16,819	$45.0K
Alpine Global Management, LLC	16,430	$43.0K
HSBC Holdings PLC	12,888	$35.0K
Equitec Proprietary Markets, LLC	12,028	$32.0K
Xponance, Inc.	11,036	$29.0K
Centiva Capital, LP	10,262	$27.0K
Point72 Hong Kong Ltd	3,103	$8.00K
Geneos Wealth Management Inc.	491	$1.00K
Spire Wealth Management	500	$1.00K
Advisory Services Network, LLC	162	$0

Not filed for Q3 2021 yet (1)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TCRT in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Pictet Asset Management Ltd	21,300	$56.0K